- Compare:
Chart data reflects last close values.
Companies in Diagnostic Substances
| Symbol | Name | Mkt Cap | Last Price | Change | Member Sentiment |
|
|---|---|---|---|---|---|---|
| ABAX | ABAXIS, Inc. |
410.53M | $18.42 | -$0.32 | -1.71% | Neutral |
| ABMC | AMER BIO MEDICA |
2.17M | $0.10 | $0.03 | 42.86% | Neutral |
| AKRX | Akorn, Inc. |
290.72M | $3.15 | -$0.08 | -2.48% | Neutral |
| AMAG | AMAG Pharmaceuticals, Inc. |
756.41M | $36.00 | -$0.28 | -0.77% | Neutral |
| APPY | AspenBio Pharma, Inc. |
27.55M | $0.69 | -$0.00 | -0.36% | Neutral |
| AVRX | Avalon Pharmaceuticals, Inc. |
14.16M | $0.59 | $0.00 | 0.00% | Neutral |
| BLUD | Immucor, Inc. |
1.26B | $17.98 | -$0.47 | -2.55% | Neutral |
| CLDX | Celldex Therapeutics, Inc |
148.09M | $4.66 | -$0.28 | -5.67% | Neutral |
| DDD | SCOLR Pharma, Inc |
23.30M | $0.46 | $0.00 | 0.00% | Neutral |
| EPCT | EpiCept Corporation |
42.71M | $0.97 | -$0.01 | -1.02% | Neutral |
| EPCTD | EpiCept Corporation |
43.32M | $1.00 | $0.00 | 0.00% | Neutral |
| ICCC | ImmuCell Corporation |
9.36M | $3.15 | $0.25 | 8.62% | Neutral |
| ICGN | Icagen, Inc. |
17.16M | $0.36 | $0.04 | 12.50% | Neutral |
| IDXX | IDEXX Laboratories, Inc. |
3.43B | $59.55 | -$1.41 | -2.31% | Neutral |
| ILI | Interleukin Genetics, Inc |
13.51M | $0.37 | -$0.03 | -7.50% | Neutral |
| IMMU | Immunomedics, Inc. |
230.32M | $3.06 | -$0.06 | -1.92% | Neutral |
| IMRX | ImaRx Therapeutics, Inc. |
637.30K | $0.01 | $0.00 | 0.00% | Neutral |
| INFI | Infinity Pharmaceuticals, Inc. |
148.93M | $5.67 | -$0.30 | -5.02% | Neutral |
| MGRM | Monogram Biosciences, Inc. |
104.59M | $4.53 | $0.00 | 0.00% | Neutral |
| MYGN | Myriad Genetics, Inc. |
1.45B | $14.80 | -$0.33 | -2.18% | Neutral |
| NEOG | Neogen Corporation |
599.11M | $26.56 | -$0.40 | -1.48% | Neutral |
| NYMX | Nymox Pharmaceutical Corporation |
104.91M | $3.30 | $0.04 | 1.23% | Neutral |
| OGXI | OncoGenex Pharmaceuticals Inc. |
77.14M | $12.10 | $0.05 | 0.42% | Neutral |
| ORCH | Orchid Cellmark Inc. |
47.95M | $1.60 | $0.00 | 0.00% | Neutral |
| ORXE | Ore Pharmaceuticals Inc |
1.97M | $0.36 | $0.00 | 0.00% | Neutral |
Diagnostic Substances
Industry Performance
| Today | 1w | 1m | 3m | YTD | 1y | 5y |
|---|---|---|---|---|---|---|
| -1.67% | -1.61% | -6.23% | -11.29% | -6.45% | 3.63% | 158.42% |
Top Members in Diagnostic Substances
-
+0.03%
-
-1.47%
-
+2.32%
* Average monthly return vs. S&P 500
Industry News
-
Drug Delivery Shares Running Late Monday
Forbes - Jun 07 at 5:30PM (EST)
-
Verso Paper, Celldex Therapeutics: Biggest Price Decliners (VRS, CLDX)
The Wall Street Journal - Jun 07 at 5:11PM (EST)
-
Zacks - May 20 at 12:59PM (EST)
-
Treating cellular codes like radio stations
Fortune - Mar 17 at 4:22AM (EST)
-
AMAG Anemia Drug Eyes Growing Market
Investor's Business Daily, Inc. - Mar 05 at 6:22PM (EST)
- Advertisement -